We are pleased to announce that the Translational Breast Cancer Research (TBCR) has attained its latest impact factor for the 2025 citation year: 3.9 (Figure 1).
Figure 1. Journal Impact Factor of TBCR
Translational Breast Cancer Research (Transl Breast Cancer Res, TBCR, Online ISSN 2218-6778) is published by AME Publishing Company, with support from Wolters Kluwer (the journal content will be made available on Wolters Kluwer Health’s Lippincott and Ovid platforms). It is an open-access, peer-reviewed journal focusing on translational research in breast cancer. As a quarterly published journal, the journal seeks to create a platform for researchers and clinicians by presenting pertinent investigations, discussing critical questions relevant to the entire field of breast cancer, and aiming to develop new perspectives for all those issues concerned with breast cancer. TBCR is indexed and covered by Web of Science [Emerging Sources Citation Index (ESCI)], PubMed/PubMed Central (PMC), and Scopus.
We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.
We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in cancer research to bring more exciting content to readers in the coming future.
2025 Journal Impact Factors of AME journals
We are also pleased to share the latest impact factors of all journals published under AME Publishing Company (Table 1).
- 37 AME journals received a Journal Impact Factor (JIF) this year, with three journals receiving their first JIF
- 12 journals have one or more categories ranked in Q1 or Q2
These achievements reflect the continuous growth and academic influence of our journal portfolio. We sincerely thank all contributors across our journals for their dedication and support.
Table 1 2025 Journal Impact Factors of AME journals
Editorial Office
Translational Breast Cancer Research